TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

1995;14:827-32.
21.264 Scott LL. Perinatal herpes: current status and obstetric management strategies. Pediatr Infect Dis J
1995;14:827-32.
21.265 Halme L et al. Human herpesvirus 6 infection of the gastroduodenal mucosa. Clin Infect Dis 2008;
46:434-9.
21.266 Ward KN. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis 2005;18:247-52.
21.267 Isaacson E et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with
encephalitis. Clin Infect Dis 2005;40:890-3.
21.268 Whitley RJ et al. Human herpesvirus 6 infection of the central nervous sytem: is it just a case of
mistaken association? Clin Infect Dis 2005;40:894-5.
21.269 Zerr DM et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell
transplant recipients. Clin Infect Dis 2002;34:309-17.
21.270 De Bolle L et al. Update on human herpesvirus 6 biology, clinical features and therapy. Clin
Microbiol Rev 2005;18:217-45.
21.271 Prober C. Sixth disease and the ubiquity of human herpesviruses. N Engl J Med 2005;352:753-5.
21.272 Zerr DM et al. A population based study of primary human herpesvirus 6 infection. N Engl J Med
2005;352:768-76.
21.273 Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 in-fections in
the immunocompetent. J Clin Virol 2005;32:183-93.
21.274 Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in
the immunocompetent. J Clin Virol 2005;32:183-93.
21.275 Zerr DM et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell
transplantation. Clin Infect Dis 2005;40:932-40.
21.276 Ward KN. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis 2005;18:247-52.
21.277 Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in
the immunocompetent. J Clin Virol 2005;32:183-93.
21.278 Hladik W et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006;355:
1331-8.
21.279 Sarid R et al. Virology, pathogenetic mechanisms and associated diseases of Kaposi sarcoma-associated
herpesvirus (human herpesvirus 8). Mayo Clin Proc 2002;77:941-9.
21.280 Wyplosz B et al. Initial human herpesvirus-8 rash and multicentric Castleman disease. Clin Infect Dis
2008;47:684-8.
21.281 Sullivan RJ et al. Epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus
disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.
Clin Infect Dis 2008;47:1209-15.
21.282 Cannon MJ et al. Human herpesvirus 8: current issues. Clin Infect Dis 2003;37:82-7.
21.283 Casper C et al. Remission of HHV-8 and HIV associated multicentric Castleman disease with ganciclovir
treatment. Blood 2004;103:1632-4.
21.284 Glezen WP. Prevention and treatment of seasonal influenza. N Engl J Med 2008;359:2579-85.
21.285 Beigel JH. Influenza. Crit Care Med 2008;36:2660-6.
21.286 Nicholson KG et al. Influenza. Lancet 2003;362:1733-45.
21.287 Couch RB. Prevention and treatment of influenza. N Engl J Med 2000;343:1778-87.
21.288 Hota S et al. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007;45:1362-8.
21.289 Harper SA et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis,
and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society
of America. Clin Infect Dis 2009;48:1003-32.
21.290 American Academy of Pediatrics. Recommendations for the prevention and treatment of influenza in
children, 2010-2011. Pediatrics 2010;126:816-26.
21.291 Rothberg MB et al. Complications of viral influenza. Am J Med 2008;121:258-64.
21.292 Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-73.
21.293 Monto AS et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza
A and B virus infections. J Infect Dis 1999;180:254-61.
21.294 Ng S et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household
transmission of influenza virus. Clin Infect Dis 2010;50:707-14.
21.295 Aoki FY et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J
Antimicrob Chemother 2003;51:123-9.
21.296 Stephenson I et al. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A
and B in children. Clin Infect Dis 2009;48:689-96.
21.297 de Jong MD et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J
Med 2005;353:2667-72.
21.298 Kiso M et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet
2004;364:759-65.
21.299 Hayden FG et al. Management of influenza in households: a prospective, randomized comparison of
oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004;189:440-9.
21.300 Yen HL et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment
for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 2005;192:665-72.
21.301 Jefferson T et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367:303-
13.
21.302 Nicoll A et al. Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation
and potential implications. Euro Surveill 2008;13.
21.303 Watts G. A/H1N1 influenza virus: the basics. Science 2009;339:368-9.
21.304 Sullivan SJ et al. 2009 H1N1 influenza. Mayo Clin Proc 2010;85:64-76.
21.305 Working Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza.
Clinical aspects of pandemic (H1N1) 2009 influenza. N Engl J Med 2010;362:1708-19.
21.306 Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin
influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15.
21.307 Peiris JS et al. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007;20:
243-67.
21.308 Uyeki TM. Human Infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical
issues. Clin Infect Dis 2009;49:279-90.
21.309 Gambotto A et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2007;371:
1464-75.
21.310 Hien TT et al. Avian influenza (H5N1) in 10 patients in Vietnam. N Engl J Med 2004;350:1179-88.